Annual report for Laurus Labs Ltd. for FY-2024
25-04-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q4 FY 24 Earnings call on April 25, 2024 at 1700 Hrs.18-04-2024
Laurus Labs Ltd - 540222 - Board Meeting Intimation for Approval Of Audited Financial Results For FY 24 And Declaration Of 2Nd Interim Dividend
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 ,inter alia, to consider and approve Audited Financial Results for FY 24 and Declaration of 2nd interim Dividend18-04-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Updates on Joint Venture
KRKA PHARMA PRIVATE LIMITED, a Joint Venture Company got Incorporated13-04-2024
Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
74(5) certificate05-04-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Acquisition
Further equity infusion in Laurus Synthesis Private Limited, a wholly owned subsidiary17-02-2024